Strong and Bitter Vegetables from Traditional Cultivars and Cropping Methods Improve the Health Status of Type 2 Diabetics: A Randomized Control Trial.
Anne Cathrine ThorupHanne Lakkenborg KristensenUlla KidmoseMax Norman Tandrup LambertLars Porskjær ChristensenXavier FrettéMorten Rahr ClausenSteen Møller HansenPer Bendix JeppesenPublished in: Nutrients (2021)
Vegetables rich in bitter-tasting phytochemicals may exert enhanced beneficial effects against key factors associated with type two diabetes (T2D). This study investigates whether selected cultivars of bitter and strong-tasting (BST) Brassica and root vegetables exert greater health benefits on T2D patients compared to equivalent modern mild and sweet tasting (MST) vegetables. A 12-week randomized, controlled, parallel intervention study involved 92 T2D patients, who were allocated three different diets: (1) 500 g daily of bitter and strong-tasting (BST) vegetables; (2) 500 g daily of mild and sweet-tasting (MST) vegetables; (3) 120 g daily MST normal diet (control). Both vegetable diets contained root vegetables and cabbages selected based on sensory differences and content of phytochemicals. Prior to and after the study, all participants underwent an oral glucose tolerance test (OGTT), 24 h blood pressure measurements, DEXA scans, and fasted blood samples. Both diets high in vegetables significantly reduced the participants' BMI, total body fat mass, and HbA1c levels compared to control, but in the BST group, significant differences were also found regarding incremental area under the curve glucose 240 min (OGTT) and fasting glucose levels. A high daily intake of root vegetables and cabbages showed significant health improvements in both vegetable groups. BST vegetables had the greatest impact on insulin sensitivity, body fat mass, and blood pressure compared to control; moreover, they further improved glycemic control compared to MST vegetables.
Keyphrases
- health risk
- human health
- health risk assessment
- blood pressure
- glycemic control
- blood glucose
- weight loss
- physical activity
- type diabetes
- healthcare
- randomized controlled trial
- heavy metals
- end stage renal disease
- mental health
- magnetic resonance imaging
- clinical trial
- chronic kidney disease
- magnetic resonance
- computed tomography
- heart rate
- adipose tissue
- body mass index
- phase ii
- open label
- contrast enhanced
- phase iii
- placebo controlled
- study protocol